Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04338971Not ApplicableCompleted

Ipsihand Device Use in Stroke Patients to Assess Functional Motor Outcomes

Role: lead

NCT05965713Not ApplicableCompleted

National Fully Remote Use of IpsiHand Device in Hemiparetic Stroke

Role: lead

NCT07147881Not Yet Recruiting

Prospective Real-World Evidence Study of the IpsiHand® System in Adult Stroke Survivors

Role: lead

NCT03611855Not ApplicableTerminated

Chronic Stroke Rehabilitation With Contralesional Brain-Computer Interface

Role: collaborator

NCT04123808Not ApplicableWithdrawn

IpsiHand System for Rehabilitation of the Arm and Hand After Stroke

Role: collaborator

All 5 trials loaded